Compliant with Alliant

Join the Alliant EB Compliance team for a discussion of what the latest PBM reforms mean for your plan, including the DOL proposed rule on PBM disclosures, the Consolidated Appropriations Act 2026 PBM reforms, the FTC litigation against 3 major PBMs, and what to do about state PBM reform laws.

Join the Alliant Employee Benefits Compliance team to discuss the fast-approaching deadline to update the HIPAA Notice of Privacy Practices, including a brief review of the HIPAA 2024 Final Privacy Rule and, specifically, which components of that Rule were vacated by a court decision, which provisions remain effective, and what plan sponsors—especially self-funded plan sponsors—should be doing now.

Join the Alliant EB Compliance team to discuss the latest trend in employer-provided GLP-1 coverage—the direct to consumer approach. Here we discuss the common structure of these programs and the compliance implications when an employer plan sponsor excludes coverage for these drugs under the plan, but reimburse employees who purchase GLP-1 coverage directly from the manufacturer. This episode will help employers better understand the vendor programs available in the marketplace and what compliance obligations they may have if they implement such a solution.

Join our benefits compliance attorneys to discuss the election results, potential regulatory changes in the short term, and policy priorities that could impact group health plans.

Join Alliant's benefits compliance attorneys for the latest guidance on preventive requirements, including birth control, breast cancer screenings, and diabetes-related care.

Join our compliance attorneys to discuss key provisions of the Internal Revenue Code that impact your group health plan and how to identify plan designs that could create risk and run afoul of the Code.

Many employers are considering covering GLP-1 drugs for weight loss, but the costs associated with this coverage can be extensive. Join Alliant’s employee benefits compliance team for a robust discussion on how to cover GLP-1 drugs without breaking the bank or the law.

From the Johnson & Johnson fiduciary breach to the Affordable Care Act preventive care mandate, to the Supreme Court’s decision overruling prior precedent in a case commonly known as Chevron—this year has been a busy one for court cases impacting group health plans.

In this episode, Alliant’s in-house employee benefits compliance attorneys discuss a number of these cases in detail and go over what employers need to know.

Join us for a special edition of Compliant with Alliant where our Compliance and Pharmacy practices team up to share some thoughts about the class action complaint filed against Johnson & Johnson. We'll go over what to consider as you evaluate not just your pharmacy benefits, but your benefit plan as a whole.

This episode is brought to you by the letter G! Listen as our employee benefits compliance experts discuss a number of hot topics including gender affirming surgery, gene therapy drugs, and gag clause attestations. Also, stick around for a health and welfare plan litigation update.